Biomarker Applications for Improved Clinical Trial Outcomes 2011 highlights the use of biomarkers and diagnostics during every stage of clinical research, to stratify patients, prove clinical validity, and streamline the regulatory approval and reimbursem November 22, 2011

Ion Channel Drug Discovery in the 21st Century will review the potential for ion channels as therapeutic targets, examine the advantages presented by the evolution of assay system technology, review choices for selection of compounds for primary screening and will present real life case study data from early stage drug discovery programs.

Matthew Gardner will present “The challenges of generating ion channel modulating antibodies.”